Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,576,071
+$5,763,695 QoQ
Shares Held
27,290
+454.4% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#155
of 640 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026L2 Asset Management, LLC holds $28,710,157 across 7 Biotechnology names. JAZZ ranks #4 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
129,324 | $7,251,196 | |
| 2 | INCY |
Incyte Corp
|
61,784 | $7,003,834 | |
| 3 | EXEL |
Exelixis, Inc.
|
125,702 | $6,839,445 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
27,290 | $6,576,071 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
952 | $593,610 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
768 | $231,191 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,147 | $214,810 |
All Filings in JAZZ
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,576,071 | 27,290 | Shares | Sole | 2026-08-13 | |
| 2020-12-31 | $812,376 | 4,922 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $795,937 | 5,582 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $876,209 | 7,941 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $927,582 | 9,300 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||